Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Biagio Ricciuti, M.D.

Concepts (231)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Biagio Ricciuti's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Biagio Ricciuti has written about over time.
Antineoplastic Agents, 18 publications between 2015 and 2023, average publication date March 2018. Gene Rearrangement, 6 publications between 2013 and 2024, average publication date December 2018. Drug Resistance, Neoplasm, 11 publications between 2015 and 2024, average publication date May 2020. Carcinoma, Non-Small-Cell Lung, 86 publications between 2013 and 2024, average publication date January 2021. Lung Neoplasms, 100 publications between 2013 and 2024, average publication date February 2021. Immunotherapy, 24 publications between 2018 and 2024, average publication date May 2021. Proto-Oncogene Proteins p21(ras), 16 publications between 2013 and 2024, average publication date June 2021. Mutation, 36 publications between 2013 and 2024, average publication date June 2021. Protein-Tyrosine Kinases, 6 publications between 2019 and 2024, average publication date December 2021.

To see the data from this visualization as text, click here.
Ricciuti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (231)
Explore
_
Co-Authors (94)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.